MU

Matthias Urmann

SA Sanofi-Aventis: 14 patents #21 of 563Top 4%
SA Sanofi: 8 patents #158 of 1,881Top 9%
SA Sanofi-Aventis: 6 patents #223 of 1,008Top 25%
AP Aventis Pharmaceuticals: 4 patents #68 of 454Top 15%
Overall (All Time): #113,774 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 26–32 of 32 patents

Patent #TitleCo-InventorsDate
7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Gregory M. Shutske, Joseph T. Strupczewski, Kenneth J. Bordeau +10 more 2009-04-21
7465806 Pyrrole-derivatives as factor Xa inhibitors Armin Bauer, Michael Wagner, Marc Nazare, Volkmar Wehner, Hans Matter 2008-12-16
7449560 Phosophoinositoglycan binding proteins Guenter Mueller, Wendelin Frick, Stefan Petry, Rudolf Schneider 2008-11-11
7365088 Indazole-derivatives as factor Xa inhibitors Marc Nazare, Volkmar Wehner, Volker Laux, Armin Bauer, Hans Matter 2008-04-29
7317027 Azaindole-derivatives as factor Xa inhibitors Marc Nazare, Volkmar Wehner, David William Will, Kurt Ritter, Hans Matter 2008-01-08
7186724 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands James Hendrix, Horst Hemmerle, Gregory M. Shutske, Jospeh T Strupczewski, Kenneth J. Bordeau +10 more 2007-03-06
7049416 Phosophoinositoglycan binding proteins Guenter Mueller, Wendelin Frick, Stefan Petry, Rudolf Schneider 2006-05-23